Advertisement

Applying DoTS adverse drug reactions classification to reports from hospital stimulated reporting

  • Andreea Farcas
  • Noemi Beatrix Bulik
  • Andreea Popa
  • Agatha Mensah Achampong
  • Camelia Bucsa
  • Cristina Mogosan
Letter to the Editor
  • 3 Downloads

To the Editor

We want to report inhere the results of an evaluation of adverse drug reactions (ADRs) using the DoTS classification [1].

We have retrospectively applied the DoTS classification on all 251 ADRs prospectively collected in two internal medicine departments from Cluj-Napoca, Romania, during January 2010–July 2012 and registered into our database. The information available for evaluation was collected by review of medical charts, patient interviews, and discussion with attending physicians. Patients’ age, sex, alcohol intake, medical history, clinical and biological relevant data, ADRs description (including causality, seriousness, treatment and outcome, response to de-challenge and re-challenge, if performed), and information on suspected drugs (dose and treatment duration) were available. Only cases with at least possible causality relation were included in the present analysis. Causality was assessed with Karch-Lasagna [2] algorithm. For all the ADRs, the Rawlins and...

Notes

Authors’ contributions

AF, NBB, AP, and AMA evaluated the cases according to the DoTS classification. AF and CM developed the study design. AF and CB were involved in acquisition, analysis, and interpretation of final data. CB and AF drafted the manuscript. All authors revised the paper critically for important intellectual content and provided the final approval of the version to be published; they also agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

228_2018_2596_MOESM1_ESM.pdf (176 kb)
ESM 1 (PDF 175 kb)
228_2018_2596_MOESM2_ESM.pdf (191 kb)
ESM 2 (PDF 190 kb)

References

  1. 1.
    Aronson JK, Ferner RE (2003) Joining the DoTS: new approach to classifying adverse drug reactions. BMJ 327(7425):1222–1225CrossRefGoogle Scholar
  2. 2.
    Karch FE, Lasagna E (1977) Towards the operational identification of adverse drug reactions. Clin Pharmacol Ther 21(3):247–254CrossRefGoogle Scholar
  3. 3.
    Rawlins MD, Thompson JW (1977) Pathogenesis of adverse drug reactions. In: Davies DM (ed) Textbook of adverse drug reactions. Oxford University Press, OxfordGoogle Scholar
  4. 4.
    Calderón-Ospina C, Bustamante-Rojas C (2010) The DoTS classification is a useful way to classify adverse drug reactions: a preliminary study in hospitalized patients. Int J Pharm Pract 18(4):230–235.  https://doi.org/10.1111/j.2042-7174.2010.00039.x CrossRefPubMedGoogle Scholar
  5. 5.
    Wiffen P, Gill M, Edwards JE, Moore A (2002) Adverse drug reactions in hospital patients. A systematic review of the prospective and retrospective studies. Bandolier ExtraGoogle Scholar
  6. 6.
    Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reaction as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 329:15–19CrossRefGoogle Scholar
  7. 7.
    Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Begaud B (2000) Adverse drug reactions in a department of systemic disease-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 55:181–186CrossRefGoogle Scholar
  8. 8.
    Lillo-Le Louet A, Puech P, Le Beller C, Le Louet H (2015) Evaluation of a new classification of adverse drugs reactions (ADR): applying DOTS to spontaneous reports. Drug Saf 38 (10):1000, Abstract P 090, ISoP 2015, PragueGoogle Scholar
  9. 9.
    Rojas-Velandia C, Ruiz-Garzón J, Moscoso-Alcina JC, Vallejos-Narvaéz Á, Castro-Canoa J, Bustos-Martínez Y (2017) Characterization of adverse drug reactions causing admission to an intensive care unit. Br J Clin Pharmacol 83(5):1134–1140.  https://doi.org/10.1111/bcp.13199 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Abubakar AR, Bin Simbak N, Haque M (2014) Adverse drug reactions: predisposing factors, modern classifications and causality assessment. RJPT 7(9):1091–1098Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Drug Information Research CenterIuliu Hatieganu University of Medicine and PharmacyCluj-NapocaRomania

Personalised recommendations